First Manhattan’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-263,375
| Closed | -$10.7M | – | 1462 |
|
|
2023
Q1 | $10.7M | Buy |
263,375
+19,657
| +8% | +$795K | 0.04% | 133 |
|
|
2022
Q4 | $11.3M | Hold |
243,718
| – | – | 0.04% | 138 |
|
|
2022
Q3 | $12.6M | Buy |
243,718
+15,911
| +7% | +$825K | 0.05% | 123 |
|
|
2022
Q2 | $10.8M | Sell |
227,807
-561,504
| -71% | -$26.5M | 0.04% | 148 |
|
|
2022
Q1 | $56.2M | Sell |
789,311
-180,425
| -19% | -$12.8M | 0.18% | 60 |
|
|
2021
Q4 | $72.5M | Hold |
969,736
| – | – | 0.24% | 54 |
|
|
2021
Q3 | $55.1M | Buy |
969,736
+936,536
| +2,821% | +$53.2M | 0.2% | 60 |
|
|
2021
Q2 | $1.46M | Buy |
+33,200
| New | +$1.46M | 0.01% | 378 |
|
|
2021
Q1 | – | Sell |
-237,679
| Closed | -$10M | – | 1487 |
|
|
2020
Q4 | $10M | Sell |
237,679
-137,206
| -37% | -$5.78M | 0.05% | 158 |
|
|
2020
Q3 | $17.2M | Sell |
374,885
-19,312
| -5% | -$884K | 0.09% | 106 |
|
|
2020
Q2 | $19.8M | Sell |
394,197
-18,000
| -4% | -$904K | 0.11% | 94 |
|
|
2020
Q1 | $21.2M | Sell |
412,197
-134,134
| -25% | -$6.9M | 0.14% | 85 |
|
|
2019
Q4 | $33.8M | Buy |
546,331
+37,701
| +7% | +$2.33M | 0.17% | 81 |
|
|
2019
Q3 | $30.6M | Sell |
508,630
-109,141
| -18% | -$6.56M | 0.17% | 86 |
|
|
2019
Q2 | $52.1M | Sell |
617,771
-47,163
| -7% | -$3.98M | 0.29% | 59 |
|
|
2019
Q1 | $63.5M | Sell |
664,934
-14,800
| -2% | -$1.41M | 0.37% | 49 |
|
|
2018
Q4 | $48.1M | Sell |
679,734
-18,700
| -3% | -$1.32M | 0.3% | 55 |
|
|
2018
Q3 | $59.7M | Buy |
698,434
+129,026
| +23% | +$11M | 0.32% | 53 |
|
|
2018
Q2 | $66M | Sell |
569,408
-302,367
| -35% | -$35M | 0.38% | 48 |
|
|
2018
Q1 | $70.5M | Sell |
871,775
-212,425
| -20% | -$17.2M | 0.4% | 43 |
|
|
2017
Q4 | $63.6M | Buy |
1,084,200
+137,100
| +14% | +$8.04M | 0.35% | 55 |
|
|
2017
Q3 | $44.3M | Buy |
947,100
+12,400
| +1% | +$580K | 0.25% | 74 |
|
|
2017
Q2 | $33.6M | Buy |
934,700
+56,200
| +6% | +$2.02M | 0.2% | 94 |
|
|
2017
Q1 | $27.1M | Buy |
878,500
+394,000
| +81% | +$12.1M | 0.16% | 104 |
|
|
2016
Q4 | $16.2M | Buy |
484,500
+311,200
| +180% | +$10.4M | 0.1% | 135 |
|
|
2016
Q3 | $4.61M | Buy |
+173,300
| New | +$4.61M | 0.03% | 251 |
|